Menu
07/02/2006
Breast cancer sufferer faces wait on drug ruling
A breast cancer sufferer will have to wait to learn the result of her legal battle against the NHS' decision not to provide her with the drug, Herceptin.
Ann Marie Rogers, 54, from Swindon, launched her case after being refused the drug, which is only licensed for the treatment of advanced breast cancer, by Swindon Primary Care Trust.
However, a High Court Judge said that he would not decide on the case immediately, because the decision was "too important".
Ms Rogers' case is the first case to come to court. If she is successful, it could lead to all PCTs being forced to provide the drug for all patients with early-stage breast cancer.
Pressure has been mounting on the NHS to provide Herceptin for patients in the early stages of breast cancer. In two other previous cases, the NHS agreed to provide the drug, which costs around £20,000 per year's treatment.
Ms Rogers had borrowed £5,000 for Herceptin treatment, but cannot afford to fund any more courses.
Launching the case at the High Court yesterday, Ms Rogers' solicitor Ian Wise said that the Trust's policy of only providing Herceptin in "exceptional cases" was "arbitrary and unlawful".
In a statement, Ms Rogers said that she felt "as though I have been given a punishment like a death sentence" and added "waiting for the cancer to return is like waiting on death row."
(KMcA)
Ann Marie Rogers, 54, from Swindon, launched her case after being refused the drug, which is only licensed for the treatment of advanced breast cancer, by Swindon Primary Care Trust.
However, a High Court Judge said that he would not decide on the case immediately, because the decision was "too important".
Ms Rogers' case is the first case to come to court. If she is successful, it could lead to all PCTs being forced to provide the drug for all patients with early-stage breast cancer.
Pressure has been mounting on the NHS to provide Herceptin for patients in the early stages of breast cancer. In two other previous cases, the NHS agreed to provide the drug, which costs around £20,000 per year's treatment.
Ms Rogers had borrowed £5,000 for Herceptin treatment, but cannot afford to fund any more courses.
Launching the case at the High Court yesterday, Ms Rogers' solicitor Ian Wise said that the Trust's policy of only providing Herceptin in "exceptional cases" was "arbitrary and unlawful".
In a statement, Ms Rogers said that she felt "as though I have been given a punishment like a death sentence" and added "waiting for the cancer to return is like waiting on death row."
(KMcA)
Related UK National News Stories
Click here for the latest headlines.
06 February 2006
Cancer drug refusal branded a 'death sentence'
A woman who has launched a landmark legal challenge to get breast cancer drug Herceptin, has compared her NHS Trust's refusal to provide the drug as a "death sentence". Ann Marie Rogers, 54, from Swindon launched the case after being refused the drug by Swindon Primary Care Trust, which is only licensed for the treatment of advanced breast cancer.
Cancer drug refusal branded a 'death sentence'
A woman who has launched a landmark legal challenge to get breast cancer drug Herceptin, has compared her NHS Trust's refusal to provide the drug as a "death sentence". Ann Marie Rogers, 54, from Swindon launched the case after being refused the drug by Swindon Primary Care Trust, which is only licensed for the treatment of advanced breast cancer.
17 October 2005
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
27 June 2014
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
12 April 2006
Breast cancer patient wins Herceptin court battle
A breast cancer patient has won an appeal to receive the drug Herceptin on the NHS. Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
Breast cancer patient wins Herceptin court battle
A breast cancer patient has won an appeal to receive the drug Herceptin on the NHS. Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
25 March 2014
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
-
Northern Ireland WeatherThis Evening and Tonight:Showers, scattered in the evening, will clear by midnight leaving the night dry with clear spells. Perhaps a touch of ground frost. Cloud will spread east towards morning. Minimum temperature 2 °C.
